People who have previously received Zostavax can receive Shingrix to increase their protection against herpes zoster, since protection using Zostavax wanes significatnly from around 5 years after vaccination.
The optimal interval between receipt of Zostavax and Shingrix may vary, but an interval of at least 12 months is recommended between receiving Zostavax and a subsequent dose of Shingrix. The person will still need to complete the 2-dose schedule of Shingrix.
If a person has previously received Zostavax through the NIP, they are not eligible to receive Shingrix through the NIP until 5 years after the Zostavax dose. If a person paid privately for a previous dose of Zostavax, they are eligible to receive Shingrix through the NIP at any time after the optimal interval.
